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Abstract
How hematopoietic stem cells (HSCs) respond to inflammatory signals during infections is not well understood. Our studies
have used a murine model of ehrlichiosis, an emerging tick-born disease, to address how infection impacts hematopoietic
function. Infection of C57BL/6 mice with the intracellular bacterium, Ehrlichia muris, results in anemia and
thrombocytopenia, similar to what is observed in human ehrlichiosis patients. In the mouse, infection promotes
myelopoiesis, a process that is critically dependent on interferon gamma (IFNc) signaling. In the present study, we
demonstrate that E. muris infection also drives the transient proliferation and expansion of bone marrow Lin-negative Sca-1
+
cKit
+ (LSK) cells, a population of progenitor cells that contains HSCs. Expansion of the LSK population in the bone marrow
was associated with a loss of dormant, long-term repopulating HSCs, reduced engraftment, and a bias towards myeloid
lineage differentiation within that population. The reduced engraftment and myeloid bias of the infection-induced LSK cells
was transient, and was most pronounced on day 8 post-infection. The infection-induced changes were accompanied by an
expansion of more differentiated multipotent progenitor cells, and required IFNc signaling. Thus, in response to
inflammatory signals elicited during acute infection, HSCs can undergo a rapid, IFNc-dependent, transient shift from
dormancy to activity, ostensibly, to provide the host with additional or better-armed innate cells for host defense. Similar
changes in hematopoietic function likely underlie many different infections of public health importance.
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Introduction
Hematopoiesis, the process that supplies the host with innate and
adaptive immune cells, is maintained by hematopoietic stem cells
(HSCs), which are capable of both self-renewal and differentiation.
Under homeostatic conditions, HSCs are thought to be largely
quiescent [1,2], and are commonly referred to as dormantHSCs,oras
long-term reconstituting HSCs (LT-HSC), as these progenitor cells
have the most robust hematopoietic potential [3]. Although all
differentiated blood cells are ultimately derived from HSCs, the daily
production of blood and immune cells is provided by more
differentiated short-term reconstituting HSCs (ST-HSCs), or multip-
otentprogenitors(MPPs).MuchisknownregardingHSCpotentialand
differentiation under homeostatic conditions, but how infections can
alter the function and phenotype of LT-HSCs is not well understood.
Under steady-state conditions, HSCs and progenitor cells can
be identified among the population of cells that lack expression of
lineage-specific markers, and express Sca-1 and c-Kit [4].
Alterations in hematopoietic stem and progenitor cell phenotype
and function have been observed in bacterial infection models,
and during sepsis [5,6,7], as evidenced by the apparent expansion
of lineage-negative (Lin-neg), Sca-1+ c-Kit+ (LSK) bone marrow
cells. Changes in the LSK population have also been observed in
mice infected with vaccinia virus and herpes simplex virus [8,9],
and in vitro studies have documented an important role for IFNc in
this process [10]. It is likely that, during infection, inflammation
acts to modulate hematopoiesis to promote the production of cells
better able to respond to and control infection.
Changes in hematopoietic cell activity caused by inflammation
or chronic bacterial infection have been associated with a
transition of HSCs from dormancy to activity, and this process
can be mediated by both type I and type II interferons [7,11]. It
has not been reported whether such a transition is a common
feature of HSC biology during acute infections, however. Here, we
have used an experimental model of ehrlichiosis to demonstrate
that a bacterial infection can cause major, although transient,
changes in hematopoietic function that is accompanied by the
transition of LT-HSCs and progenitors from dormancy to activity.
This process is associated with an IFNc-dependent expansion of
more differentiated hematopoietic progenitor cells. Our data
support a model whereby infection-induced IFNc acts on normally
quiescent HSCs to undergo transient activation, in order to
promote an expedited innate immune response.
Results
Infection-induced LSK cells exhibit altered functional
potential
In our previous studies, we demonstrated that Ehrlichia muris
infection induces major changes to the bone marrow compart-
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28669ment, and enhances myelopoiesis [6,12]. We initiated the present
study to address whether the altered myelopoeisis we had observed
was accompanied by changes in bone marrow HSC phenotype
and/or function. Such changes were suggested, as, following
infection of C57BL/6 mice, we observed an expansion of bone
marrow LSK cells (Fig. S1A). By day 8 post-infection, the
frequency of LSK cells increased by approximately ten-fold,
relative to uninfected mice; this increase in frequency correspond-
ed to a 5-fold increase in the number of LSK cells within the bone
marrow (Fig. S1B and C). The apparent expansion of the LSK
population was in part due to cell proliferation, as the frequency of
LSK cells that had proliferated within a 4-hour interval on day 8
post-infection was increased by three-fold, compared to uninfected
mice (Fig. S1D and E). The frequency of proliferating LSK cells
detected on day 16 post-infection was also increased, compared to
uninfected mice, but was not as high as that in mice analyzed on
day 8 post-infection. The number of BrdU-positive LSK cells
among total bone marrow cells was also increased, by over ten-
fold, compared to uninfected mice, on both days post-infection
(Fig.S1F).
Several published studies have described the phenotypic
characterization of HSCs and MPPs, but it is not well understood
how the phenotype and function of these populations may change
under inflammatory conditions associated with infection. HSCs
are found in the fraction of LSK cells that lack surface expression
of CD34 and CD135 [13,14], although many reports have
documented significant heterogeneity within this cell population
[15,16,17]. During E. muris infection, the frequency and number of
LSK CD342 CD1352 cells increased, suggesting that infection
promotes the proliferation of true HSCs (Fig. 1A–C).
Figure 1. Altered phenotype of LSK cells during bacterial infection. (A) Bone marrow LSK cells were monitored for surface expression of
CD34 and CD135. The numbers in the plots represent the frequencies of cells within the gated region; the analysis was performed on total bone
marrow cells. (B, C) The frequency and number of LSK CD342 CD1352 cells is shown. (D) LSK cells were examined for surface expression of CD150
and CD135. The numbers in the plots represent the frequency of the LSK CD150+ CD1352 cells among total bone marrow cells. (E) The total number
of LSK CD150+ CD1352 cells was determined. (F) BrdU incorporation was measured in the LSK CD150+ CD1352 population 4 hours post-
administration. (G and H) The frequency of BrdU-positive cells within the LSK CD150+ CD1352 population is indicated. (I)The LSK CD150+ CD1352
cells shown in D were analyzed for the expression of CD34 and CD48. The numbers in the plots represent the frequency of CD48-positive or -negative
cells among the LSK CD150+ CD1352 cells. The flow cytometry plots represent analyses of single mice; the graphs summarize data pooled from at
least three mice per group, and are representative of two experiments. A student’s t test was performed to evaluate statistically significant differences
(* indicates p,0.05, and ** indicates p,0.001). In each case comparisons were made between the uninfected mice and infected mice.
doi:10.1371/journal.pone.0028669.g001
Activation of HSPCs during Acute Infection
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28669In a model of sepsis, LT-HSCs (i.e., dormant HSCs;
characterized as CD150+ CD1352 LSK cells) were found to
increase in number [5]. We observed a similar increase in the bone
marrow LSK CD150+ CD1352 population during ehrlichial
infection (Fig. 1D, E), and these cells were found to incorporate
BrdU, suggesting the expansion of the population was, in part, due
to proliferation (Fig. 1F–H). This was consistent with the
observation that LSK CD342 CD1352 cells increased during
infection. However, given the magnitude of the response, we
reasoned that the infection-induced LSK CD150+ CD1352
population were not LT-HSCs. To address this in greater detail,
we examined the LSK CD150+ CD1352 population for its
expression of additional markers of hematopoietic differentiation.
One such marker, CD48, is a member of the signaling lymphocyte
activation marker (SLAM) family, and has been shown to be
expressed on multipotent progenitor cells, and is also a marker of
actively dividing cells [18,19]. We observed that, at homeostasis,
the LSK CD150+ CD1352 population expressed low levels of
CD48, but that the infection-induced LSK CD150+ CD1352
cells uniformly expressed high amounts of CD48 (Fig. 1I),
indicating that these latter cells were unlikely true LT-HSCs.
To further evaluate the function of bone marrow LT-HSCs
during infection, we next evaluated the capacity of the infection-
induced LSK cells to reconstitute hematopoietic lineages in
lethally-irradiated recipient mice. LSK cells were purified from
uninfected, or E. muris-infected mice, on days 8 and 16 post-
infection, and were transferred into irradiated, congenic recipient
mice, along with 2610
5 radioprotective bone marrow cells
(Fig. 2A). Peripheral blood from the recipient mice was analyzed
for donor cell chimerism 4 weeks post-reconstitution. Whereas
approximately 50% of the peripheral blood cells were LSK-donor-
derived in mice that received LSK cells from uninfected mice,
fewer than 10% of hematopoietic cells were LSK donor-derived in
mice that received LSK cells purified from mice on day 8 post-
infection (Fig. 2B). LSK cells obtained from mice on day 16 post-
infection exhibited more efficient engraftment, relative to LSK
cells obtained on day 8 post-infection; however, the day 16 LSK
cells engrafted less efficiently than the LSK cells purified from
uninfected mice (Fig. 2C). Thus, during infection, the proliferative
status of the LSK population was inversely correlated with its
engraftment potential, a finding that is consistent with reports that
have demonstrated an inverse relationship between HSC prolif-
eration and function [1]. Thus, despite the apparent increase in
phenotypically-identified HSCs, the frequency of functionally-
defined HSCs was decreased within the bone marrow LSK
population during acute ehrlichial infection.
We next addressed the capacity of the LSK cells from infected
mice to contribute to different lineage-positive subsets within the
peripheral blood. LSK cells purified on day 8 post-infection gave
rise to higher relative frequencies of CD11b/Gr-1-positive
myeloid cells than LSK cells purified from either uninfected or
day 16-infected donor mice, when examined at 4 weeks post-
transplantation (Fig. 2D). This myeloid-bias was relatively short-
lived, however; by 16 weeks post-reconstitution there were fewer
LSK-donor myeloid cells in the periphery of chimeras that
received the day 8-infected LSK cells. LSK cells obtained from
mice on either day 8 or 16 post-infection also gave rise to very few
T cells at 4 weeks post-transplantation; however the frequencies of
T cells increased significantly by 16 weeks post-reconstitution and
were comparable among all groups at that time.
To verify that lineage potential of the transferred LSK cells in
irradiated recipients was due to changes in their differentiation,
and not a consequence of secondary bacterial infection in the
irradiated recipients, we addressed whether the purified LSK cells
contained any bacteria. Bacterial DNA was undetectable in
purified LSK cells, but it was possible that small numbers of
bacteria were transferred during transplantation. Therefore, we
also examined the spleens of irradiated recipient mice for bacterial
colonization. The LSK cells did not transmit infectious bacteria,
whereas transfer of infected splenocytes resulted in robust bacterial
growth in the spleen (Fig. S2). Thus, the transient increase in the
frequency of myeloid-committed progenitor cells within the LSK
population was not a consequence of persistent bacterial infection
in transplantation recipients.
LSK cells from infected mice were less efficient at
providing long-term hematopoietic reconstitution
To determine the long-term hematopoietic potential of the
infection-induced LSK population, radiation-induced chimeric
mice that were reconstituted with purified LSK cells, and with
radioprotective bone marrow cells, were examined 200 days post-
reconstitution. We observed similar frequencies and numbers of
LSK cells among the groups of mice that received LSK cells from
uninfected, or E. muris-infected mice (Fig. 3A and B), indicating
that the LSK cell reconstitution occurred normally in the chimeric
mice. In mice that received LSK cells from uninfected mice, the
LSK donor cells composed the majority of the recipient LSK
population, likely because there were higher frequencies of HSCs
within that donor population. In contrast, chimeric mice that
received LSK cells purified from E. muris-infected mice contained
a much lower percentage of LSK-donor-derived cells; instead, the
majority of the LSK population was composed of competitor-
derived cells (Fig. 3C and D). These data indicate that the
infection-induced LSK population contained fewer LT-HSCs with
engraftment potential, relative to uninfected mice. Some long-term
reconstituting potential, nonetheless, remained within the LSK cell
population during infection.
Infection was associated with an IFNc-dependent
expansion of bone marrow multipotent progenitor cells
IFNc expression is induced by infection with E. muris (Fig. S3),
and IFNc signaling is required for protection against E. muris
infection [6]. Our previous data demonstrated that IFNc is an
important modifier of hematopoiesis during bacterial infection [6],
so we also addressed whether the changes in hematopoietic
progenitor and stem cells were IFNc-dependent, by examining
these populations in IFNcR-deficient mice during acute infection.
The infection-induced expansion of LSK cells was significantly
reduced in the IFNcR-deficient mice, as compared to wild-type
mice (Fig. S4). These data suggest that IFNc plays a major role in
stem cell activation.
We characterized the LSK population in greater detail in wild
type and IFNcR–deficient mice, using a strategy defined by
Wilson et al., who identified LT-HSCs as LSK CD150+ CD482
CD342 CD1352 cells [3]. Similar to the findings reported in that
study, we found that the LSK CD150+ CD482 population
exhibited the lowest proliferation, as measured by BrdU
incorporation ([3]; Fig. S5). On day 8 post-infection, the number
of LSK CD150+ CD482 CD342 CD1352 cells was significantly
reduced in the bone marrow, relative to the same population in
uninfected mice (Fig. 4A and B); however, by day 16 post-
infection the number of phenotypically described LT-HSCs was
equivalent to those observed in uninfected mice. We also
characterized other bone marrow progenitor cells, on the basis
of CD48 expression. On day 8 post-infection the number of LSK
CD150+ CD482 CD34+ CD1352 cells was decreased, but the
more differentiated LSK CD150+ CD48+ CD34+ CD1352 and
Activation of HSPCs during Acute Infection
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number (Fig. 4B). The decrease in the LSK CD150+ CD482
CD34+ CD1352 population was not observed in the IFNcR-
deficient mice, and the increase in the LSK CD150+ CD48+ and
LSK CD1502 CD48+ cells was less marked (Fig. 4B). These data
together suggest that infection-induced loss of phenotypically-
Figure 2. LSK cells purified from infected mice have reduced engraftment potential and are myeloid-biased. (A) The schematic
illustrates the protocol used for generation of the bone marrow chimeric mice. Bone marrow LSK cells were purified by flow cytometry, and the LSK
cells (1610
4; CD45.1) were mixed with whole bone marrow (2610
5; CD45.2), and were transferred into lethally-irradiated C57BL/6 mice (CD45.2). (B)
At 4 weeks post-reconstitution, peripheral blood was analyzed for donor cell engraftment. (C) The frequencies of LSK-derived cells in the blood of the
chimeric mice are shown at 4 weeks and 16 weeks post-reconstitution. (D) The frequency of peripheral blood myeloid lineage cells (CD11b+/Gr1+), B
cells (B220+), and T cells (CD3+), among LSK donor-derived cells (CD45.1), was determined at 4 weeks and 16 weeks post-reconstitution. A student’s
t test was performed to evaluate statistically significant differences (* indicates p,0.05, and ** indicates p,0.001). In each case comparisons were
made between the mice that received LSK cells from uninfected mice and mice that received LSK cells from infected mice. Significant differences
observed between week 4 and 16 post-transplantation are indicated by the brackets.
doi:10.1371/journal.pone.0028669.g002
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PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e28669Figure 3. Long-term repopulating activity of LSK cells is diminished during infection. (A) The bone marrow of chimeric mice, described in
Fig. 2, were analyzed 200 days post-reconstitution. The frequency of the LSK cells, among Lin-negative cells, is shown. (B) The average number of LSK
cells in the bone marrow harvested from both femurs is shown for each group. (C) The LSK population was evaluated for expression of CD45.1. (D)
The frequency of LSK donor-derived cells is shown. A student’s t test was performed to evaluate statistically significant differences (* indicates
p,0.05, and ** indicates p,0.001).
doi:10.1371/journal.pone.0028669.g003
Figure 4. Infection induces an IFNc-dependent transient depletion of dormant HSCs and a concomitant expansion of MPPs.
Hematopoietic progenitor cells were identified in the bone marrow of wild type and IFNcR-deficient mice during acute E. muris infection. (A) LSK cells
were examined for surface expression of CD150 and CD48 on days 8 and 16 post-E. muris infection in C57BL/6 and IFNcR-deficient mice. The numbers
represent the frequencies of cells, among LSK cells, in each region. (B) The LSK CD150+CD482 (highlighted by the green boxes), LSK CD150+CD48+
(blue), and LSK CD1502CD48+ (red) cell populations shown in A were evaluated for expression of CD34 and CD135; the number of cells in each
population is shown. Data from wild-type (colored histograms) and IFNcR-deficient mice (unshaded histograms) are shown. A student’s t test was
performed to evaluate statistically significant differences. The numbers of cells in each population in uninfected mice were compared to the
equivalent population in infected mice. Statistical significance is indicated for the wild-type mice (* indicates p,0.05, and ** indicates p,0.001), and
IFNcR-deficient mice (# indicates p,0.05). Significant differences between wild type and IFNcR-deficient mice are indicated by the brackets.
doi:10.1371/journal.pone.0028669.g004
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is accompanied by the expansion of more differentiated progenitor
cells.
As Sca-1 expression can be modulated by IFNc signaling, it was
possible that the changes we observed in cell phenotype were a
consequence of altered Sca-1 regulation. To address this concern,
we examined the Lin- cKit+ population for expression of CD150
and CD48, as these surface antigens are not known to be regulated
by IFNc. The number of Lin-cKit+ cells increased during
infection in wild type mice, but decreased in the IFNcR-deficient
mice (Fig. S6A), thus the population changes were detected using
cell surface markers other than Sca-1. Similarly, the Lin2 cKit+
CD150+ CD482 population declined, while the CD150+ CD48+
and CD1502 CD48+ populations increased in number (Fig. S6B
and C). These changes were dependent upon IFNc signaling, and
the findings are consistent with a role for IFNc in driving
proliferation of the HSCs and progenitor cells. Thus, these data
support our previous study that demonstrated an important role
for IFNc in regulating myelopoiesis during infection, and are
consistent with published studies that have described a role for
interferons in activating quiescent HSCs [7,11].
Our data also suggested that IFNc may act directly on HSCs.
To test the hypothesis that IFNc signaling mediated the activation
of the dormant HSC population, we used a label-retaining cell
assay to identify dormant HSCs [3,20]. Wild type and IFNc-
deficient mice were administered BrdU for 12 days, after which
time treatment was suspended. Under such experimental condi-
tions, HSCs that incorporated BrdU prior to entrance into a
dormant state, retain BrdU for greater than 100 days, and can be
detected by flow cytometry [3,20]. Similar frequencies and
numbers of BrdU-positive Lin-negative cells were detected in wild
type and IFNc-deficient mice 165 days after BrdU treatment
(Fig. 5A and B). When these mice were analyzed 7 days following
E. muris infection, we observed a five-fold reduction in the number
Lin-negative BrdU-positive cells in wild type C57BL/6 mice, but
only a small decrease in the number of Lin-negative label-retaining
bone marrow cells in infected IFNc-deficient mice. These data
support a role for IFNc in activating dormant HSCs and/or
hematopoietic progenitor cells during acute bacterial infection.
As an additional test for our hypothesis that IFNc signaling acts
on HSCs during infection, we performed competitive reconstitu-
tion assays, using purified LSK cells obtained from wild type
(EGFP-transgenic, GFP+, CD45.2+) and IFNcR-deficient mice
(GFP2, CD45.2+)( Fig. 6A). The LSK cells were harvested on
day 8 post E. muris infection, and equal numbers of donor cells
were transferred into lethally irradiated congenic CD45.1 mice. At
4 weeks post-transfer, we observed that the LSK cells purified from
the IFNcR-deficient mice engrafted much more efficiently than
the wild type cells (Fig. 6B and C). Thus, we conclude that IFNc
promotes the activation of dormant hematopoietic stem and
progenitor cells during E. muris infection.
Discussion
Our study demonstrates that HSCs can undergo a transition
from a dormant state to an active state during an intracellular
bacterial infection. This conclusion is based on our observations
that LSK cells isolated from the bone marrow during infection
exhibited increased proliferation, reduced engraftment, and a loss
of long-term repopulating potential, all characteristics of activated
HSCs. Although it has been demonstrated that HSCs can be
activated by IFNc during chronic mycobacterial infection [7], our
study demonstrates that HSC activation can also occur during
acute bacterial infection, and, can be reversed quite rapidly. We
demonstrate that this transition from dormancy to activation is
IFNc-dependent, supporting the notion that IFNc acts on HSCs
during inflammation. Similar changes in HSCs have been shown
to occur following IFNa expression, induced by poly I:C treatment
in vivo [11]. Thus, an emerging paradigm is that IFNs control the
basal state of the dormant HSC population. As most infections
trigger the production of IFNs, we postulate that the transient
activation of dormant HSCs is a common occurrence.
Among hematopoietic cells, expression of the a chain of the
IFNc receptor is highest in dormant LT-HSCs [7], consistent with
the observation that HSC activation by IFNc occurs via direct
signaling on this cell population. Although we have not shown in
this study that IFNc acts directly on HSCs during ehrlichiosis,
such a conclusion is strongly supported by our previous data, and
other published studies that demonstrated that IFNc-responsive
genes, such as Adar and Irgm1, are activated in and required by
HSCs in response to inflammatory-stress [21,22]. IFNc signaling
under homeostatic conditions does not appear to be essential, as
IFNc and IFNcR-deficient mice exhibit normal hematopoiesis
and bone marrow cellularity.
Figure 5. Infection-induced loss of label-retaining cells was dependent on IFNc. Wild type and IFNcdeficient mice administered BrdU
water, ad libitum for 12 days; the mice were mock-infected or E. muris-infected 165 days following BrdU withdrawal, and analyzed 7 days later. (A)
BrdU-positive cells within the Lin-negative fraction of bone marrow is displayed for both mock-infected (left) and E. muris-infected mice at day 7 post-
infection; numbers indicate the frequency of Lin-negative BrdU+ cells among total bone marrow cells. (B) The total number of Lin-negative BrdU+
cells in the bone marrow is shown. Statistical significance is indicated between the mock and infected groups (* indicates p,0.05), and significant
differences between wild type and IFNc-deficient mice are indicated by the brackets.
doi:10.1371/journal.pone.0028669.g005
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dormancy to activity in order to promote the expansion of more
differentiated progenitor cells, such as myeloid-biased MPPs. This
interpretation is consistent with our previous findings that
intracellular ehrlichial infection induced myelopoiesis [6]. In that
study we demonstrated that direct IFNc signaling in promyelo-
cytes resulted in the expression of transcription factors essential for
the proper differentiation of granulocytes and monocytes. The
changes we have observed are not limited to the ehrlichia. We
have observed similar changes to the hematopoietic compartment
during influenza and Mycobacterium tuberculosis infections (KM and
GW, unpublished data), and similar IFNc–directed alterations in
hematopoiesis have been reported during malarial infection [23].
IFNc signaling has been considered to be detrimental during
chronic infection [7], but we propose that IFNc signaling is
essential for activating the hematopoietic response to infection,
and for the production of innate immune cells required for
combating infection.
Hematopoietic stem and progenitor cells express Toll like
receptors (TLRs), and it has been shown that these cells can be
directed to differentiate upon direct interaction with TLR ligands
[9,24,25]. In addition, chronic exposure to LPS, which can
stimulate cells via TLR4, results in phenotypic and functional
changes within the HSC population [26]. It has been proposed
that circulating HSCs and progenitor cells express TLRs so that
they can respond directly to pathogens, and differentiate in situ,i n
non-lymphoid tissues [27]. E. muris is not known to encode
canonical TLR-ligands, so it is likely that IFNc provides an
alternative mechanism to activate HSCs.
Prospective isolation of HSCs based on cell surface marker
expression has been an important focus of hematopoiesis research,
and has relied on the use of cell surface markers to facilitate the
enrichment of cells with the most potent self-renewal and
differentiation potential. During infection, expression of inflam-
matory cytokines, such as IFNc, can modulate the expression of
cell surface proteins used to identify stem and progenitor cells [6].
We have shown that the LSK population, which contains HSCs,
undergoes phenotypic and functional changes during ehrlichial
infection, similar to findings obtained in studies of viral, parasitic,
and other bacterial infections [8,23,24,28]. Initially, we observed
that the number of LSK CD342 CD1352 cells increased during
infection, which suggested that the LSK population contained
more HSCs. However, our studies demonstrated that the
infection-induced LSK cells exhibited poor engraftment, indicat-
ing that the LSK CD342 CD1352 cell population contained few
LT-HSCs. We showed that the decreased engraftment potential of
the LSK population on day 8 post-infection correlated with a
decrease in the number of dormant HSCs, where dormant HSCs
were characterized as LSK CD150+ CD482 CD1352 CD342
cells. By day 16 post-infection, when the dormant HSC population
was found to recover, we observed a similar increase in LSK
engraftment potential. In a model of cecal ligation-induced
bacterial sepsis, LT-HSC cells were shown to expand significantly
within the bone marrow [5], findings which are in apparent
contradiction to our own. However, in the study by Scumpia et al.,
the authors defined LT-HSCs as LSK CD150+ CD1352 cells.
Whereas we, too, found that this population expanded during
ehrlichiosis, we observed high expression of CD48 on these cells.
Thus, we conclude that the LSK CD150+ CD1352 CD48+ cells
represent more differentiated MPPs, not LT-HSCs. Thus,
additional phenotypic markers may be required to distinguish
LT-HSCs from more differentiated progenitor cells under
inflammatory conditions.
Figure 6. IFNc signaling reduces engraftment efficiency of LSK cells during infection. (A) Equal numbers of LSK cells derived from wild
type (EGFP-expressing; CD45.2) and IFNcR-deficient (GFP-neg; CD45.2+) mice on day 8 post-infection were mixed and transplanted in competitive
reconstitution experiments. (B) Four weeks post-transplant engraftment efficiency was measured in the peripheral blood by donor cell chimerism.
The blood from recipient mice (CD45.1+) was analyzed for donor LSK cells (CD45.2+ that were wild type or IFNcR-deficient cells, as determined by
expression of GFP. The frequency of GFP+ CD45.2 wild type and GFP2 CD45.2 cells is displayed. Statistical significance is indicated between the
groups.
doi:10.1371/journal.pone.0028669.g006
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28669Our findings, together with the studies from other laboratories,
demonstrate that infections can mediate profound changes to
HSCs by driving, via interferons, their transient conversion from a
state of dormancy to activity. It will be important to gain a better
understanding of how IFNc mediates the activation of dormant
HSCs, how IFNc signaling is regulated in these cells, and how this
process impacts host defense during infectious diseases of public
health significance.
Materials and Methods
Ethics Statement
All animal studies were approved by the Wadsworth Center
Animal Care and Use Committee (protocol number: 08-326). The
Wadsworth Center is in compliance with all federal and state
guidelines for the use of animals in research (assurance number:
A3183-01).
Mice
Mice were obtained from the Jackson Laboratory (Bar Harbor,
ME), or were bred in the Animal Care Facility at the Wadsworth
Center under microisolater conditions. C57BL/6 mice and the
following transgenic and gene-targeted strains were used: IFNcR1-
deficient (B6.129S7-Ifngr1
tm1Agt/J; described in this study as
IFNcR-deficient), IFNc-deficient (B6.129S7-Ifng
tm1Ts/J), EGFP-
transgenic (C57BL/6-Tg(ACTB-EGFP)1Osb/J), and a CD45
congenic strain (B6.SJL-Ptprc
a Pepc
b/BoyJ).
Bacteria
Mice were infected, via intraperitoneal injection, between 6 and
12 weeks of age, with 50,000 bacteria obtained from infected
mouse splenocytes, as previously described [12,29].
Flow cytometry and antibodies
Bone marrow mononuclear cells were harvested and prepared
as previously described [12]. The antibodies used for flow
cytometry included the following: biotin-conjugated lineage
markers specific for CD3 (clone 17A2), CD11b (M1/70), Ly-6G
(RB6-8C5), Ter119 (Ly-76), CD45R (RA3-6B2), phycoerythrin
(PE)-cychrome-7 (Cy7)-conjugated Sca-1 (D7), peridinin chloro-
phyll protein (PerCP)-Cy5.5-conjugated CD45.2 (104), Alexa700-
CD45.2 (104), PE-conjugated-CD45.1, PerCP-Cy5.5-CD150
(TC15-12), allophycocyanin (APC)-conjugated c-Kit (2B8), PE-
CD135 (D2F10), FITC-conjugated CD34 (RAM34), APC-Cy7-
streptavidin, and eFluor450-streptavidin (eBiosciences, SanDiego,
CA), as well as Pacific Blue-CD48 (HM48-1; BioLegend,
SanDiego, CA). Unstained cells were used as negative controls
to establish the flow cytometer voltage settings, and single-color
positive controls were used to adjust the instrument compensation.
The flow cytometric data were acquired using an LSR II flow
cytometer (BD Biosciences), and data analysis was performed
using FlowJo software (TreeStar, Ashland, OR).
BrdU administration and detection
For short-term studies, BrdU (0.8 mg) was administered to
mice, via the intraperitoneal route, in a single injection. Four hours
post-administration, BrdU incorporation was assessed by intracel-
lular staining, using a FITC-conjugated anti-BrdU monoclonal
antibody (PRB-1; BD Biosciences), and cells were analyzed on an
LSR II flow cytometer. For label retaining cell assays, mice were
placed on BrdU water (0.8 mg/mL plus 10% dextrose) for 12
days. BrdU incorporation was assessed by intracellular staining as
described above.
Flow cytometric cell sorting
LSK cells were identified using FITC-conjugated lineage
markers, PE-conjugated Sca-1, and APC-conjugated c-Kit. The
LSK population was purified using an Aria II flow cytometer
equipped with FACSDiva software (BD Biosciences); the purity of
the sorted populations was greater than 90% in all experiments.
Generation of bone marrow chimeras
C57BL/6 mice (CD45.2) mice were lethally irradiated (950
RADs, administered in 2 doses, 3 hours apart), and were
reconstituted with 1610
4 purified LSK cells, obtained from
mock-infected or E. muris-infected CD45.1 congenic mice, and
2610
5 bone marrow cells obtained from C57BL/6 mice. For
competitive transplantation experiments, LSK cells were puri-
fied on day 8 post-E. muris infection from EGFP-transgenic
C57BL/6 and IFNcR-deficient mice. LSKc e l l sw e r em i x e da ta
1:1 ratio (1610
3 cells of each population), and transplanted into
lethally radiated CD45.1 recipient mice (with and 2610
5 bone
marrow cells obtained from congenic CD45.1 mice for
radioprotection).
Statistical analyses
Statistical analyses were performed with a Student’s t-test, using
Prism GraphPad Software (LaJolla, CA); a P value of,0.05 was
considered to be significant.
Supporting Information
Figure S1 Bacterial infection induces an expansion of bone
marrow LSK cells.
(TIF)
Figure S2 Purified LSK cells do not transmit E. muris to
irradiated transplantation recipients.
(TIF)
Figure S3 IFNc production is induced by E. muris infection.
(TIF)
Figure S4 Expansion of the LSK population in C57BL/6 and
IFNcR-deficient mice.
(TIF)
Figure S5 BrdU incorporation in LSK subpopulations.
(TIF)
Figure S6 Analysis of SLAM expression on lineage-negative
cKit-positive cells during infection.
(TIF)
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